• Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • A study of fosfomycin trometamol treatment for male urinary tract infections in primary care settings

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Gene Therapy Study for Familial Hemophagocytic Lymphohistiocytosis Using MUNC-CD34 and MUNC-T3 in Patients with UNC13D Gene Mutations

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Botulinum Toxin Type A for Treating Buerger’s Disease in Patients Eligible for Injection Therapy

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    France
  • Study of methylprednisolone effects on recovery after major surgery in elderly patients aged 60 and over

    Not yet recruiting

    3 1 1
    Belgium
  • Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Poland
  • Study of Propofol and Thiopental for anesthesia induction in newborns under 47 weeks postmenstrual age

    Not yet recruiting

    3 1 1 1
    Denmark
  • Study on Spironolactone for Maintaining Sinus Rhythm in Hypertensive Patients with Atrial Fibrillation and Preserved Heart Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by